Ignite Creation Date:
2025-12-25 @ 4:01 AM
Ignite Modification Date:
2026-03-09 @ 2:15 AM
Study NCT ID:
NCT04284202
Status:
UNKNOWN
Last Update Posted:
2020-02-25
First Post:
2020-02-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PD-1 Combined With Dasatinib for as Third-line Treatment for ARID1A Mutation Advanced NSCLC
Sponsor:
The Affiliated Hospital of Qingdao University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IOT-ARID1A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None